Velcicky, J., Bodendorf, U., Rigollier, P., Epple, R., Beisner, D., Guerini, D., … Brandl, T. (2018). Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.7b01371 (Original work published 2018)